Marco Taglietti - Articles and news items

AstraZeneca
AstraZeneca

AstraZeneca and Forest Laboratories to initiate phase III clinical trials for ceftazidime/avibactam

Industry news, News / 18 October 2011 / AstraZeneca

ceftazidime/avibactam (CAZ-AVI) will enter phase III trials…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+